The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription by Katagiri Naohiro et al.
The nucleolar protein nucleophosmin is
essential for autophagy induced by inhibiting
Pol I transcription
著者 Katagiri Naohiro, Kuroda Takao, Kishimoto
Hiroyuki, Hayashi Yuki, Kumazawa Takuya,
Kimura Keiji
journal or
publication title
Scientific reports
volume 5
page range 8903
year 2015-03
権利 This work is licensed under a Creative Commons
Attribution 4.0 International License. The
images or other third party material in this
article are included in the article's Creative
Commons license, unless indicated otherwise in
the credit line; if the material is not
included under the Creative Commons license,
users will need to obtain permission from the
license holder in order to reproduce the
material. To view a copy of this license,
visit
http://creativecommons.org/licenses/by/4.0/
URL http://hdl.handle.net/2241/00124554
doi: 10.1038/srep08903
Creative Commons : 表示
http://creativecommons.org/licenses/by/3.0/deed.ja
The nucleolar protein nucleophosmin is
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Various cellular stresses activate autophagy, which is involved in lysosomal degradation of cytoplasmic
materials for maintaining nutrient homeostasis and eliminating harmful components. Here, we show that
RNA polymerase I (Pol I) transcription inhibition induces nucleolar disruption and autophagy. Treatment
with autophagy inhibitors or siRNA specific for autophagy-related (ATG) proteins inhibited autophagy but
not nucleolar disruption induced by Pol I transcription inhibition, which suggested that nucleolar
disruption was upstream of autophagy. Furthermore, treatment with siRNA specific for nucleolar protein
nucleophosmin (NPM) inhibited this type of autophagy. This showed that NPMwas involved in autophagy
when the nucleolus was disrupted by Pol I inhibition. In contrast, NPM was not required for canonical
autophagy induced by nutrient starvation, as it was not accompanied by nucleolar disruption. Thus, our
results revealed that, in addition to canonical autophagy, there may be NPM-dependent autophagy
associated with nucleolar disruption.
E
ukaryotic cells are continuously exposed to various types of stress; thus, activating an adaptive response to
alleviate stress is necessary to maintain cellular homeostasis1. One of the key response pathways that
removes stress is macroautophagy (hereafter referred to as autophagy)1–4. Autophagy is an intracellular
system that degrades cytoplasmic material, such as proteins and organelles, by encircling it in double-membrane
vesicles, designated autophagosomes, for delivery to lysosomes1–4. Lysosomes contain a variety of proteases and
other acid hydrolases and ultimately degrade this material1–4. In addition, recent reports indicate that selective
forms of autophagy, such asmitophagy, pexophagy and nucleophagy, mediate selective removal ofmitochondria,
peroxisomes and parts of the nucleus, respectively1,5–7. Autophagy is widely conserved among eukaryotes ranging
from yeasts to humans and is strictly regulated by autophagy-related (ATG) proteins2,4.
Autophagy is induced by various types of stress1,5. Autophagy is primarily induced by nutrient stress due to
depletion of various nutrients, such as amino acids, glucose and growth factors1,3,5. Nutrient stress-induced
autophagy degrades cytoplasmic materials and recycles them to maintain nutrient and energy homeostasis,
which allows cells to survive under nutrient starvation conditions. For example, yeasts with a deficient autophagy
mechanism exhibit poor survival under starvation conditions8. Furthermore, mice with knockout of ATG3,
ATG5 or ATG7, which are essential for autophagy, die within 1 day after birth, indicating that autophagy is
important formouse survival during the early neonatal starvation period3. The studies described below reveal that
autophagy is also induced by other types of stress, such as hypoxia, UV irradiation, chemical compounds and heat
shock1,3,5. Under these conditions, cells adapt to the stress by activating autophagy to eliminate damaged proteins
and organelles1,3,5.
A recent study revealed that the nucleolus, the nuclear component considered to be the site of RNA polymerase
I (Pol I)-dependent ribosomal RNA (rRNA) synthesis and a ‘ribosome factory,’ acts as a stress sensor9–13. A
number of external and internal insults induce nucleolar stress by disrupting nucleolar structure, which leads to
translocation of several nucleolar proteins from the nucleolus to the nucleoplasm, such as nucleophosmin (NPM;
also called B23) and nucleostemin and ribosomal proteins, such as RPS7, RPL5, RPL11 and RPL2311,14,15. These
translocated proteins cause accumulation and activation of tumour suppressor p53 by interacting with the p53
inhibitor HDM2 and inhibiting HDM2 activity directed towards p5311,14,15. We recently found that a nucleolar
protein, Myb-binding protein 1a (MYBBP1A), is anchored to the nucleolus via nucleolar RNA16. A number of
insults inhibited Pol I transcription and reduced nucleolar RNA levels, which caused MYBBP1A to translocate
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from the nucleolus to the nucleoplasm16. The translocated MYBBP1A
activated p53 by enhancing the interaction between p53 and p300,
which induced p53 acetylation16. Taken together, the nucleolus is
regarded as a stress sensor that regulates the location of nucleolar
proteins and activates p53 under various stress conditions.
Thus, the nucleolus acts as a stress sensor9–13, and autophagy is a
response to various types of stress1–4. A number of stresses, such as
hypoxia, UV irradiation, chemical compounds and heat shock,
induce nucleolar disruption10,12 and autophagy17–21. Furthermore,
nucleolar disruption and autophagy are enhanced in mouse medium
spiny neurons by conditional knockout of the RNA Pol I-specific
transcription initiation factor-IA (TIF-IA)22. A decrease in rRNA
synthesis and nucleolar disruption have been reportedly observed
in animal models for a variety of neurodegenerative diseases, includ-
ing Huntington’s disease and Parkinson’s disease22–25, against which
autophagy has protective roles3,26,27. In contrast, increased rRNA
synthesis and an enlarged nucleolus are observed in tumour cells28–30
with high levels of autophagy31–33. Thus, it is speculated that altered
nucleolar structure may be related to inducing autophagy.
Here we show that inhibiting Pol I transcription in cells using
specific inhibitors and by siRNA treatment induces nucleolar dis-
ruption and autophagy. Furthermore, we found that the nucleolar
protein NPM played a key role activating autophagy induced by
nucleolar disruption. In contrast, NPM was not essential for canon-
ical autophagy induced by nutrient starvation, which was not accom-
panied by nucleolar disruption.
Results
Inhibiting Pol I transcription induces nucleolar disruption and
autophagy. To explore the relationship between nucleolar structure
and autophagy, we treated cells with a Pol I transcription inhibitor to
induce nucleolar disruption and assessed whether this treatment
induced autophagy. To assay for autophagy, we generated MCF-7
cells that stably expressed the enhanced green fluorescent protein
(EGFP)-tagged human microtubule-associated protein 1 light chain
3B (LC3B) protein (MCF-7/EGFP-LC3B cells).We treated these cells
with 200 nM adriamycin (ADR), which inhibits Pol I transcription
and induces autophagy (Fig. 1)19,34. After ADR treatment, the
nucleolar marker protein nucleolin (NCL) was translocated from
the nucleolus to the nucleoplasm, which indicated nucleolar
disruption (Fig. 1a). Immunostaining of these cells with an anti-
GFP antibody showed that ADR treatment enhanced formation of
EGFP-LC3B punctate structures, an indicator of autophagy (Fig. 1a
and Supplementary Fig. S1a). To further ascertain whether ADR
treatment induced autophagy, we assayed for the conversion of
LC3B-I to LC3B-II and p62 protein levels by immunoblotting.
ADR treatment induced the conversion of LC3B-I to LC3B-II
(Fig. 1b) and reduced p62 protein levels (Fig. 1b), both of which
are indicators of autophagy. These results show that ADR
treatment induced both nucleolar disruption and autophagy.
Furthermore, we tested whether another Pol I transcription inhib-
itor, actinomycin-D (ActD), could induce nucleolar disruption and
autophagy. We treated MCF-7/EGFP-LC3B cells with low-dose ActD
(5 nM), which specifically inhibits RNA polymerase I- but not RNA
polymerase II- or RNA polymerase III-driven transcription35,36. As
with ADR treatment, ActD induced nucleolar disruption and
enhanced formation of EGFP-LC3B punctate structures (Fig. 1c
and Supplementary Fig. S1b). In addition, it facilitated the conversion
of LC3B-I to LC3B-II and reduced p62 protein levels (Fig. 1d). Taken
together, these results indicate that the Pol I transcription inhibitors
ADR and ActD induced both nucleolar disruption and autophagy.
ADR and ActD are DNA intercalators that induce DNA breaks by
interacting between stacked base pairs19,34,35. Thus, these drugs induce
nucleolar disruption and autophagy by inhibiting Pol I transcription
or damaging DNA. To distinguish between these possibilities, Pol I
transcription was specifically inhibited by treatment with siRNA
specific for TIF-IA, a basal Pol I transcription factor13,37 or siRNA
specific for the polymerase (RNA) I polypeptide A (POLR1A), a Pol I
catalytic subunit38. This finding shows that, in agreement with pre-
vious reports, depleting TIF-IA caused nucleolar disruption13,16, as
shown by translocation of the nucleolar marker protein NCL from
the nucleolus to the nucleoplasm (Fig. 2a). This treatment inhibited
rRNA transcription (Supplementary Fig. S2a) and enhanced p53
protein level (Supplementary Fig. S2b), reflecting the induction of
nucleolar stress. The TIF-IA siRNA treatment induced formation of
EGFP-LC3B punctate structures (Fig. 2a and Supplementary Fig.
S2c). Furthermore, TIF-IA knockdown induced the conversion of
LC3B-I to LC3B-II and reduced the p62 protein levels (Fig. 2b).
Similar results were found when MCF-7/EGFP-LC3B cells were
treated with siRNA specific for POLR1A (Fig. 2 and Supplementary
Fig. S2). Taken together, inhibiting Pol I transcription induced both
nucleolar disruption and autophagy, suggesting an association
between nucleolar disruption and autophagy. However, it is unknown
whether nucleolar disruption induces autophagy or vice versa.
Figure 1 | RNA Pol I transcription inhibitors induced nucleolar
disruption and autophagy. (a, c) Pol I transcription inhibitors induced
nucleolar disruption and the formation of EGFP-LC3B punctate
structures. MCF-7/EGFP-LC3B cells were treated with 0.2 mMadriamycin
(ADR) (a) or 5 nM actinomycin-D (ActD) (c) for 24 h. The cells were
fixed and examined by fluorescence microscopy. The cells were stained
with anti-GFP (for LC3B; green) and anti-nucleolin (NCL; red) antibodies
to detect LC3B and NCL. The lower left graph shows the percentages of
cells with NCL staining in the nucleoplasm (NP). The lower right graph
shows the number of EGFP-LC3B puncta per cell. Results are expressed as
mean 6 standard deviation of triplicate experiments. (b, d) The Pol I
transcription inhibitors induced conversion of LC3B-I to LC3B-II and
reduced the p62 protein level. MCF-7/EGFP-LC3B cells were treated with
0.2 mM ADR (b) or 5 nM ActD (d) for the indicated times. Cell lysates
were prepared and analysed by immunoblotting using anti-GFP (for
LC3B-I and LC3B-II), anti-p62 and anti-b-actin antibodies. Complete
scans of the blots are presented in Supplementary Figures S11 and S12.
www.nature.com/scientificreports
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Depleting ATG proteins and autophagy inhibitors repress
autophagy, but not nucleolar disruption induced by TIF-IA
knockdown. To dissect the autophagy induced by inhibiting Pol I
and to investigate the relationship between nucleolar disruption and
this type of autophagy in more detail, we depleted the ATG proteins
or treatedMCF-7/EGFP-LC3B cells with autophagy inhibitors. First,
we depleted Beclin 1 (BECN1) and ATG5, both of which are ATG
proteins involved in autophagy. BECN1, together with VPS15,
VPS34 and Ambra 1, comprise the BECN1 complex, which is
essential for allosteric activation of the class III phosphoinositide
3-kinases (PI3-kinase) to generate phosphatidylinositol-3-phoshate
required for the initial stages of autophagosome formation1,2,39.
ATG5 forms a protein complex with ATG12 and ATG16L1 and
catalyses the conversion of LC3-I to LC3-II1,2,39. Knocking down
BECN1 or ATG5 repressed the formation of EGFP-LC3B punctate
structures induced by TIF-IA siRNA treatment without inhibiting
NCL translocation from the nucleolus to the nucleoplasm (Fig. 3a
and Supplementary Fig. S3a). BECN1 or ATG5 knockdown also
inhibited the conversion of LC3B-I to LC3B-II caused by depleting
TIF-IA (Fig. 3b). These results indicate that the ATG proteins
BECN1 and ATG5 are involved in autophagy induced by TIF-IA
knockdown, as well as other cases of reported autophagy, but that
depleting BECN1 or ATG5was independent of nucleolar disruption.
Furthermore, we tested the effects of autophagy inhibitors on nuc-
leolar disruption and autophagy induced by TIF-IA knockdown. 3-
Methyladenine (3-MA), a well-known autophagy inhibitor, inhibits
PI3-kinase activity and blocks the initial stages of autophagosome
formation39. To test whether 3-MA inhibits autophagy induced by
TIF-IA knockdown, we treated MCF-7/EGFP-LC3B cells with 3-MA.
The formation of EGFP-LC3B punctate structures induced by TIF-IA
knockdown was inhibited by 3-MA treatment without inhibiting
NCL translocation (Fig. 3c and Supplementary Fig. S3b). Moreover,
3-MA suppressed the conversion of LC3B-I to LC3B-II (Fig. 3d).
Furthermore, we tested the effects of the autophagy inhibitor
bafilomycin A1, a specific vacuolar type H1-ATPase inhibitor.
Bafilomycin A1 prevents the degradation of autophagosomes by
inhibiting the fusion of autophagosomes with lysosomes, which
results in an apparent accumulation of the autophagy apparatus4,39.
Among TIF-IA siRNA-treated cells, bafilomycin A1 treatment
increased the number of cells with the EGFP-LC3B punctate struc-
tures but did not affect localisation of NCL in MCF-7/EGFP-LC3B
cells (Fig. 3e and Supplementary Fig. S3c). The immunoblotting
results showed that bafilomycin A1 increased LC3B-II protein levels
in TIF-IA siRNA-treated cells (Fig. 3f). Taken together, treatment
with ATG protein siRNAs or autophagy inhibitors, all we tested,
influenced autophagy, but did not markedly affect affected nucleolar
disruption. Based on these results, nuclear disruption is upstream of
autophagy in those cells in which Pol I transcription was inhibited.
These results also suggest that inhibiting Pol I induces autophagy in a
mechanism similar to that of general autophagy.
TIF-IA knockdown induces autophagy in the absence of active
p53. Several groups, including ours, have reported that nucleolar
disruption enhances p53 activity and the expression of multiple
p53 target genes11,16. Furthermore, p53 activation is reportedly
involved in activating autophagy in mouse medium spiny
neurons22. Thus, autophagy was possibly induced by activating p53
when Pol I transcription was inhibited, and the nucleolus was
disrupted (Figs. 1 and 2).
To test whether p53 is essential for autophagy induced by inhib-
iting Pol I, we treated MCF-7/EGFP-LC3B cells with a combination
of p53 siRNA and TIF-IA siRNA (Fig. 4a and b). p53 and TIFI-A
double knockdown caused nucleolar disruption, formation of the
EGFP-LC3B punctuate structures (Fig. 4a and Supplementary Fig.
S4), and the LC3B-I to LC3B-II conversion, as well as reduced p62
levels (Fig. 4b). These results indicate that p53 was dispensable for
autophagy induced by inhibiting Pol I in MCF-7/EGFP-LC3B cells.
We then treated HeLa cells, in which p53 is inactivated40,41, with
TIF-IA siRNA and inhibited Pol I transcription (Supplementary Fig.
S5a). As a result, nucleolar structures disappeared in these cells after
Figure 2 | Knockdown of RNA Pol I transcription factors induced nucleolar disruption and autophagy. (a, c) TIF-IA or POLR1A knockdown induced
nucleolar disruption and the formation of EGFP-LC3B punctate structures. MCF-7/EGFP-LC3B cells were treated with siRNAs specific for luciferase
(siCont), TIF-IA (siTIF-IA#1) or POLR1A (siPOLR1A#1) for 60 h. Immunofluorescent staining and the statistical analysis were performed in the same
manner as shown in Figure 1 (a, c). Results are expressed as mean 6 standard deviation of triplicate experiments. (b, d) TIF-IA or POLR1A knockdown
induced conversion of LC3B-I to LC3B-II and reduced the p62 protein level. MCF-7/EGFP-LC3B cells were treated with siRNAs specific for luciferase
(siCont), TIF-IA (siTIF-IA#1 and #2) or POLR1A (siPOLR1A#1 and #2) for the indicated times. Cell lysates were analysed by immunoblotting in the same
manner as shown in Figure 1 (b, d). Complete scans of the blots are presented in Supplementary Figures S13 and S14.
www.nature.com/scientificreports
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TIF-IA siRNA treatment, as shown by translocation of NCL from the
nucleolus to the nucleoplasm (Fig. 4c). Immunostaining of these cells
with an anti-LC3 antibody showed that the TIF-IA siRNA treatment
induced formation of endogenous LC3 punctate structures (Fig. 4c
and Supplementary Fig. S5b). Immunoblotting results showed that
the TIF-IA siRNA treatment increased LC3-II levels and reduced p62
protein levels (Fig. 4d and Supplementary Fig. S5c). Taken together
with the results of MCF-7/EGFP-LC3B cells depleted of p53 and
HeLa cells, autophagy was induced independently of activating p53
when TIF-IA was depleted.
NPM is required for autophagy induced by inhibiting Pol I.
Because inhibiting Pol I transcription induced nucleolar disruption
and autophagy, there was a possible relationship between nucleolar
Figure 3 | TIF-IA knockdown-dependent autophagy is repressed by autophagy factor knockdown or by autophagy inhibitors. (a) Knocking down
BECN1 and autophagy protein 5 (ATG5) repressed formation of the EGFP-LC3B punctate structures dependent on TIF-IA knockdown. MCF-7/EGFP-
LC3B cells were treated with combinations of the indicated siRNAs for 60 h. Immunofluorescent staining and the statistical analysis were performed in
the samemanner as shown in Figure 1. (b) Knocking down BECN1 and ATG5 repressed conversion of LC3B-I to LC3B-II.MCF-7/EGFP-LC3B cells were
treated with the indicated siRNAs for 60 h. Cell lysates were prepared and analysed by immunoblot. (c) 3-Methyladenine (3-MA) repressed formation of
the EGFP-LC3B punctate structures dependent on TIF-IA knockdown. MCF-7/EGFP-LC3B cells were treated with siCont or siTIF-IA#1 for 36 h before
treatment without or with 3 mM3-MA for 12 h. Immunofluorescent staining and the statistical analysis were performed in the samemanner as shown in
Figure 1. (d) 3-MA repressed the LC3B-I to LC3B-II conversion dependent on TIF-IA knockdown. MCF-7/EGFP-LC3B cells were treated with the
indicated siRNAs for 36 h before treatment without or with 3 mM3-MA for the indicated times. Cell lysates were prepared and analysed by immunoblot.
(e) Bafilomycin A1 enhanced formation of the EGFP-LC3B punctate structures dependent on TIF-IA knockdown.MCF-7/EGFP-LC3B cells were treated
with siCont or siTIF-IA#1 for 48 h before treatment without or with 100 nM bafilomycin A1 for 2 h. Immunofluorescent staining and the statistical
analysis were performed in the samemanner as shown in Figure 1. (f) Bafilomycin A1 enhanced accumulation of the LC3B-II protein dependent on TIF-
IA knockdown. MCF-7/EGFP-LC3B cells were treated with the indicated siRNAs for 48 h before treatment without or with 100 nM bafilomycin A1 for
the indicated times. Cell lysates were prepared and analysed by immunoblot. Results are expressed mean 6 standard deviation of triplicate experiments.
Complete scans of the blots are presented in Supplementary Figures S15–S17.
www.nature.com/scientificreports
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disruption and autophagy. One possibility is that some nucleolar pro-
teins that were translocated from the nucleolus induced autophagy.
To test this possibility, we screened for nucleolar proteins that were
involved in activating autophagy in HeLa cells. We generated a siRNA
library directed against mRNAs for nucleolar proteins42 and examined
the effects of each siRNA on the conversion of LC3-I to LC3-II in cells,
treated with TIF-IA siRNA. Based on these screening results, we
focused on NPM, which is abundant in various cell types, is a multi-
functional protein and is primarily localised to the nucleolus43–46. In
addition, a role has not been previously shown for NPM during the
induction of autophagy. Thus, we examined NPM function during the
induction of autophagy.
We first ascertained that NPM was translocated from the nuc-
leolus when Pol I was inhibited in MCF-7/EGFP-LC3B cells
(Supplementary Fig. S6a and Supplementary Fig. S7a), as described
in the previous reports13,16,22. To assess whether NPMwas involved in
the autophagy induced by inhibiting Pol I, we depleted TIF-IA and/
or NPM in MCF-7/EGFP-LC3B cells and tested for the formation
of EGFP-LC3B punctate structures (Fig. 5a and Supplementary
Fig. S6b). The immunostaining results showed that NPM siRNA
repressed formation of the EGFP-LC3B punctate structures induced
by TIF-IA knockdown (compare panels 7 and 8, Fig. 5a), without
affecting NCL translocation (compare panels 3 and 4, Fig. 5a).
Furthermore, we conducted a transmission electronmicroscopy ana-
lysis to observe autophagic vacuoles. The electron microscopy ana-
lysis showed that TIF-IA knockdown increased the number of
autophagic vacuoles, which were suppressed by NPM knockdown
(Fig. 5b and Supplementary Fig. S8). Consistent with these immuno-
staining and electron microscopy results, depleting NPM counter-
acted the enhanced conversion of LC3B-I to LC3B-II induced by
TIF-IA knockdown in MCF-7/EGFP-LC3B cells (Fig. 5c).
Furthermore, we tested for the effect of inhibiting POLR1A
(Supplementary Fig. S7). NPM knockdown repressed formation of
the EGFP-LC3B punctate structures and the conversion of LC3B-I to
LC3B-II induced by POLR1A siRNA treatment (Supplementary Fig.
S7b–d). These results were similar to those when TIF-IA siRNA was
depleted. Thus, our findings indicate that NPM is essential for the
autophagy induced by inhibiting Pol I transcription.
Figure 4 | TIF-IA knockdown induces autophagy in the absence of active p53. (a) TIF-IA knockdown induced nucleolar disruption and formation of the
LC3B punctate structures in the absence of p53. MCF-7/EGFP-LC3B cells were treated with combinations of indicated siRNAs for 60 h.
Immunofluorescent staining and the statistical analysis were performed as shown in Figure 1. (b) TIF-IA knockdown induced conversion of LC3B-I to
LC3B-II and reduced the p62 protein level in the absence of p53. MCF-7/EGFP-LC3B cells were treated with siRNAs specific for luciferase (siCont), p53
(sip53#1 and #2) or TIF-IA (siTIF-IA#1) for the indicated times. Cell lysates were analysed by immunoblot. (c) TIF-IA knockdown induced nucleolar
disruption and formation of the LC3 punctate structures inHeLa cells. HeLa cells were treated with siCont (panels 1 and 3) or siTIF-IA#1 (panels 2 and 4)
for 60 h. The cells were fixed and stainedwith anti-LC3, which recognises endogenous LC3 proteins (green; panels 1 and 2) and anti-nucleolin (red; panels
3 and 4) antibodies. The statistical analysis was performed in the samemanner as shown in Figure 1. Results are expressed asmean6 standard deviation of
triplicate experiments. (d) TIF-IA knockdown induced conversion of LC3-I to LC3-II and reduced the p62 protein level in HeLa cells. HeLa cells were
treatedwith siCont or siTIF-IA#1 (siTIF-IA) for 48, 60 and 72 h. Cell lysates were analysed by immunoblot using the indicated antibodies. Complete scans
of the blots are presented in Supplementary Figures S18 and S19.
www.nature.com/scientificreports
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Previous reports showed that NPM enhances p53 accumulation
under nucleolar disruption conditions14,28,47. Thus, NPM may have
enhanced autophagy by activating p53. However, our results indicate
that depleting NPM compromised autophagy induced by depleting
TIF-IA without reducing the p53 level (Supplementary Fig. S9).
These results suggest that the autophagy induced by NPM was inde-
pendent of p53 activation.
NPM knockdown does not affect starvation-induced autophagy.
Finally, we tested whether NPM is required for the autophagy induced
by cell starvation (Fig. 6 and Supplementary Fig. S10). Nucleolar
structures were little affected by serum and amino acid starvation or
by treatments with bafilomycin A1 or NPM siRNA (Fig. 6a: panels 1–
8). Incubating control siRNA-treated cells in starvationmedia induced
formation of the EGFP-LC3B punctate structures (Fig. 6a: panel 10),
which was enhanced in the presence of bafilomycin A1 (Fig. 6a: panel
12). Similar results were obtained with NPM siRNA-treated cells;
starvation induced formation of the EGFP-LC3B punctate structures
(Fig. 6a: panel 14), which was enhanced by bafilomycin A1 (Fig. 6a:
panel 16). To further evaluate the involvement of NPM in starvation-
induced autophagy, we examined conversion of LC3B-I to LC3B-II by
immunoblotting (Fig. 6b). NPM knockdown had little effect on
conversion of LC3B-I to LC3B-II induced by starvation and/or in
bafilomycin A1 treated-cells (Fig. 6b). These results indicate that
NPM is not involved in the autophagy induced by starvation.
We summarise our findings in Figure 6c. Our experimental results
have revealed that nucleolar disruption by inhibiting Pol I transcrip-
tion induced autophagy. Furthermore, we found that the nucleolar
protein NPM is essential for autophagy induced by inhibiting Pol I
transcription. In contrast, NPMwas not involved in canonical autop-
hagy induced by nutrient starvation. This result suggests that in
addition to canonical autophagy, NPM-dependent autophagy
induced by Pol I transcription inhibition exists (Fig. 6c).
Discussion
Recent reports have indicated that the nucleolus is involved in vari-
ous cellular processes, such as cell cycle regulation, cell proliferation
and stress response, in addition to a primary function as the site of
ribosome biogenesis9–11,42. The relationship between the nucleolus
and various human diseases has also been suggested22,23,28,29. In this
study, we found that autophagy was induced when the nucleolus was
experimentally disrupted by several methods (Figs. 1 and 2), reflect-
ing the relationship between the nucleolus and autophagy. In addi-
tion, we revealed that nucleolar disruption was upstream of
autophagy in cells in which Pol I transcription was inhibited using
siRNAs for ATG proteins or autophagy inhibitors, because they
influenced autophagy without affecting nucleolar disruption
(Fig. 3). Recent reports indicate the presence of nucleophagy, which
is a selective form of autophagy that removes and degrades damaged
or non-essential parts of the nucleus7,48. We found no evidence of
nucleophagy when the nucleolus was disrupted; however, it is intri-
guing to test for the presence of nucleophagy because Pol I inhibition
may influence nuclear structures, including nucleolar dynamics.
There are two possible mechanisms by which nucleolar disruption
could induce autophagy; one is that reduced protein synthesis via a
reduced number of ribosomes causes autophagy9,13, and the other is
Figure 5 | NPM knockdown represses RNA Pol I transcription factor knockdown-dependent autophagy. (a) NPM knockdown repressed formation of
the EGFP-LC3B punctate structures dependent on TIF-IA knockdown. MCF-7/EGFP-LC3B cells were treated with siCont (panels 1 and 5), siNPM#1
(panels 2 and 6), siTIF-IA#1 and siCont (panels 3 and 7) or siTIF-IA#1 and siNPM#1 (panels 4 and 8) for 60 h. Immunofluorescent staining and the
statistical analysis were performed in the samemanner as shown in Figure 1. Results are expressed asmean6 standard deviation of triplicate experiments.
(b) Electron micrographs indicate that NPM knockdown repressed autophagy dependent on TIF-IA knockdown. MCF-7 cells were treated with siCont
(panel 1), siTIF-IA#1 and siCont (panel 2) or siTIF-IA#1 and siNPM#1 (panel 3) for 60 h, followed by observations under a transmission electron
microscope. Autophagic vacuoles (autophagosomes and autolysosomes) are indicated by the arrowheads. Bar, 1 mm. Lower number denotes the
percentage of the area of autophagic vacuoles to the cytoplasmic area. (c) NPM knockdown repressed conversion of LC3B-I to LC3B-II dependent on
TIF-IA knockdown.MCF-7/EGFP-LC3B cells were treated with siCont (lane 1), siTIF-IA#1 and siCont (lanes 2 and 3), siNPM#1 (lane 4), siTIF-IA#1 and
siNPM#1 (lanes 5 and 6), siNPM#2 (lane 7) or siTIF-IA#1 and siNPM#2 (lanes 8 and 9) for the indicated times. Cell lysates were analysed by immunoblot.
Complete scans of the blots are presented in Supplementary Figure S20.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 8903 | DOI: 10.1038/srep08903 6
that translocation of nucleolar proteins causes autophagy11,15. The
formermechanism is unlikely because cycloheximide, an inhibitor of
protein synthesis, does not enhance autophagy49,50. To test the latter
possibility, we screened for nucleolar proteins, the knockdown of
which compromised autophagy induced by Pol I inhibition. On
the basis of these results, we focused on NPM, which is abundant
in various cell types, and is a multifunctional protein localised prim-
arily to the nucleolus43–46.
NPMknockdown inhibited autophagy without affecting nucleolar
disruption when Pol I transcription factors were depleted (Fig. 5 and
Supplementary Fig. S7). Furthermore, NPM was not essential for
canonical autophagy induced by nutrient starvation stress, which
did not induce nucleolar disruption (Fig. 6a and b). On the basis of
this result, NPMmay have induced autophagy when nucleolar struc-
ture was disrupted by Pol I inhibition, a mechanism different from
that involved in canonical autophagy (Fig. 6c). A previous study
showed that p53 is implicated in autophagy induced by nucleolar
stress22. Thus, NPM may enhance autophagy by activating p53, as
NPM enhances the accumulation and activation of p5314,47.
However, our screening results showed that NPM was also involved
in autophagy of HeLa cells, which are cells that do not have active
p53. Furthermore, NPM knockdown compromised autophagy with-
out reducing the p53 level (Supplementary Fig. S9). On the basis of
these results, it is likely that NPM-induced autophagy is independent
of p53 activation under our conditions. Thus, NPM- and p53-
dependent pathways may be present independently in the autophagy
induced by nucleolar disruption (Fig. 6c).
Autophagy is reportedly related to various diseases, such as neu-
rodegenerative diseases and tumours3,26,27,31–33. In addition, abnor-
malities in nucleolar structure are observed in such diseases22–25,28–30.
Figure 6 | NPM knockdown has little effect on starvation-induced autophagy. (a) NPM knockdown had little effect on formation of the EGFP-LC3B
punctate structures induced by starvation. MCF-7/EGFP-LC3B cells were treated with siCont (panels 1–4 and 9–12) or siNPM#1 (panels 5–8) for 60 h.
After the siRNA treatment, the cells were cultured in standard medium (Cont.; panels 1, 3, 5, 7, 9, 11, 13 and 15) either without (panels 1, 5, 9 and 13) or
with bafilomycin A1 (Baf; panels 3, 7, 11 and 15) or in starvationmedium (HBSS; panels 2, 4, 6, 8, 10, 12, 14 and 16) either without (panels 2, 6, 10 and 14)
or with bafilomycin A1 (Baf; panels 4, 8, 12 and 16) for 2 h. The cells were fixed and examined by fluorescence microscopy. Immunofluorescent staining
and the statistical analysis were performed in the same manner as shown in Figure 1. Results are expressed as mean 6 standard deviation of triplicate
experiments. (b) NPM knockdown did not affect conversion of LC3B-I to LC3B-II induced by starvation. MCF-7/EGFP-LC3B cells were treated with
siCont (lanes 1–4), siNPM#1 (lanes 5–8) or siNPM#2 (lanes 9–12) for 60 h. After siRNA treatment, cells were cultured in standardmedium (Cont.; lanes
1, 3, 5, 7, 9 and 11) either without (lanes 1, 5 and 9) or with bafilomycin A1 (Baf; lanes 3, 7 and 11) or in starvationmedium (HBSS; panels 2, 4, 6, 8, 10 and
12) either without (lanes 2, 6 and 10) or with bafilomycin A1 (lanes 4, 8 and 12) for 2 h. Cell lysates were analysed by immunoblot. Complete scans of the
blots are presented in Supplementary Figure S21. (c) Proposed model for nucleolar disruption-dependent autophagy.
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A decrease in rRNA transcription and reduced nucleolar volume are
found in animal models of various neurodegenerative diseases22–25.
Furthermore, targeted disruption of the nucleolus by conditional
TIF-IA ablation results in a mouse model with neurodegenerative
disease-like phenotypes22,24. Thus, nucleolar stress and its resultant
shrinking nucleolus is one of the causes of neurodegenerative dis-
eases. Several lines of evidence indicate that autophagy has neuro-
protective functions3,26,27. For example, disruption of the nucleolus in
response to nucleolar stress activates p53, which enhances autophagy
and prolongs neural survival, along with PTEN22; although, the effect
of p53 on neural survival is biphasic; p53 causes cell death by indu-
cing apoptosis23. Moreover, neural cell-specific Atg5 or Atg7 con-
ditional knockout mice develop neurodegenerative diseases51,52,
indicating the importance of autophagy to prevent such diseases.
In addition, NPM translocates from the nucleolus to the nucleoplasm
in response to nucleolar stress12,13. Overexpression of NPM is neu-
roprotective in cellular models53. Taken together with our results
showing that NPM has a critical role in the induction of autophagy
by nucleolar disruption (Fig. 5 and Supplementary Fig. S7), NPM
may have a role in alleviating neuronal diseases by inducing autop-
hagy. Thus, NPM could be a molecular drug target or be used in a
strategy to cure neuronal disease.
Next, we discuss tumours. An increase in rRNA synthesis and an
enlarged nucleolus are tumour hallmarks28–30, in contrast to neuro-
degenerative diseases. Autophagy is enhanced in tumour cells31–33;
however, the link between autophagy and the nucleolus has not been
established. We propose that NPM could be a key molecule. NPM is
overexpressed in various tumour types, including gastric, colon,
ovarian and prostate43,54,55. NPM promotes tumour progression by
enhancing cell proliferation and inhibiting cell differentiation and
apoptosis43,54,55. Translocation of NPM to the cytoplasm, which is
caused by a mutation in the NPM nucleolar localisation domain, is
detected in.30% of primary acute myelogenous leukaemia cells56,57.
Thus, translocation of NPM may enhance cancer progression by
facilitating autophagy, which is related to tumorigenesis; autophagy
suppresses tumour growth during the initiation stage, although it
also plays a critical role in tumour progression andmaintenance58–60.
If this is the case, then inhibiting autophagy would enhance the effect
of anti-cancer drugs in tumours with translocated NPM, as inhib-
iting autophagy enhances the cytotoxic effects of some anti-cancer
agents31–33,60. Alternatively, inhibition or downregulation of NPM
could lead to a new cancer therapy strategy.
Methods
Cell culture.MCF-7 human breast cancer cells and HeLa human cervical cancer cells
were maintained in DMEM (Sigma, St. Louis, MO, USA) as previously described16.
Plasmids. Full-length cDNA encoding human LC3B was amplified by polymerase
chain reaction (PCR) using total DNA isolated fromMCF-7 cells. PCR amplification
was conducted using the following primers: human LC3B forward, 59-
GGCGAATTCGATGCCGTCGGAGAAGACCTTC-39 and reverse, 59-
GGCGTCGACTTACACTGACAATTTCATCCC-39. cDNA was cloned into the
pEGFP-C1 vector (Invitrogen, Carlsbad, CA, USA) to generate the pEGFP-C1-LC3B
plasmid.
Generation of stable cell lines. MCF-7 cells were transfected with the pEGFP-C1-
LC3B plasmid using Lipofectamine LTX&Plus Reagent (Invitrogen) according to the
manufacturer’s guidelines. Selective pressure was applied 48 h after transfection
using DMEM containing 0.5 mg/ml G418. At least five stable transgenic clones were
isolated after 14 days.
siRNA transfection. siRNA transfection was performed as previously described16. In
brief, Cells at 30–50% confluence were transfected with 20 nM siRNA (see below)
using Lipofectamine RNAiMAX (Invitrogen) for 48–72 h according to the
manufacturer’s protocol.
Antibodies. The anti-GFP, anti-p62/SQSTM1, anti-BECN1, anti-ATG5 and anti-
LC3 antibodies were purchased from MBL International (Woburn, MA, USA) (598,
PM045, PM017, M153-3 and PM036, respectively). Anti-b-actin and anti-p53
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA)
(sc-47778 and sc-126, respectively). The anti-NCL antibody was purchased from
Abcam (Cambridge, MA, USA) (ab-13541) and anti-NPM antibody was purchased
from Invitrogen (32-5200).
Immunofluorescent staining. Cells grown on chamber slides were washed with
phosphate-buffered saline (PBS; 140 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4 and
8.1 mM Na2HPO4) and fixed in 4% paraformaldehyde phosphate buffer solution
(Wako Pure Chemical, Osaka, Japan) for 10 min. After washing twice with PBS, the
cells were permeabilised in 0.1% Triton X-100 in PBS and blocked with 0.1% Triton
X-100 in PBS containing 1% bovine serum albumin and 10% foetal bovine serum for
1 h at room temperature. Then the MCF-7/EGFP-LC3B cells were incubated with
anti-GFP, anti-NCL or anti-NPM antibodies, and HeLa cells were incubated with
anti-LC3, anti-NCL or anti-NPM antibodies for 6 h at 4uC. After washing with 0.1%
Triton X-100 in PBS, the cells were incubated with Alexa Fluor 488- and 594-
conjugated secondary antibodies (Invitrogen) for 1 h and mounted with Vectashield
(Vector Laboratories, Burlingame, CA, USA). Immunofluorescence signals were
detected by Biorevo BZ-9000 immunofluorescence microscopy (Keyence, Osaka,
Japan). More than 150 cells were determined in triplicate experiments to quantify the
number of EGFP-LC3B and LC3 puncta. More than 100 cells were determined in
triplicate experiments to quantify the number of cells with translocated NCL.
siRNA. All siRNAs were purchased from Invitrogen. The following sequences were
used: human TIF-IA#1-siRNA sense:
59-CGACACCGUGGUUUCUCAUGCCAAU-39 and antisense:
59-AUUGGCAUGAGAAACCACGGUGUCG-39; human TIF-IA#2-siRNA sense:
59-AGGAUGUCUGCUAUGUAGAUGGUAA-39 and antisense,
59-UUACCAUCUACAUAGCAGACAUCCU-39; human POLR1A#1-siRNA sense:
59-CCUAGGAGACCAGAUGUUUACUAAU-39 and antisense:
59-AUUAGUAAACAUCUGGUCUCCUAGG-39; human POLR1A#2-siRNA sense:
59-CAACAGCAAGUUGACUAUCACGUUU-39 and antisense:
59-AAACGUGAUAGUCAACUUGCUGUUG-39; human BECN1-siRNA sense:
59-CCACUCUGUGAGGAAUGCACAGAUA-39 and antisense:
59-UAUCUGUGCAUUCCUCACAGAGUGG-39; human ATG5-siRNA sense:
59-CAAAGAAGUUUGUCCUUCUGCUAUU-39 and antisense:
59-AAUAGCAGAAGGACAAACUUCUUUG-39; human p53#1-siRNA sense:
59- UUCCGUCCCAGUAGAUUACCACUGG-39 and antisense:
59- CCAGUGGUAAUCUACUGGGACGGAA-39; human p53#2-siRNA sense:
59- GCUUCGAGAUGUUCCGAGAGCUGAA-39 and antisense:
59- UUCAGCUCUCGGAACAUCUCGAAGC-39; human NPM1#1-siRNA sense:
59-GAUGACUGACCAAGAGGCUAUUCAA-39 and antisense:
59-UUGAAUAGCCUCUUGGUCAGUCAUC-39 and human NPM1#2-siRNA
sense: 59-UGUAUGGAAUGUUAUGAUAGGACAU-39 and antisense:
59-AUGUCCUAUCAUAACAUUCCAUACA-39. The StealthTM RNAi Luciferase
Reporter Control Duplex was used as a control.
Immunoblotting. Immunoblotting was performed as previously described16 with
minor modifications. The membranes were blocked with 3% skim milk in TBS-T
buffer (20 mM Tris-HCl, pH 7.5; 150 mM NaCl and 0.05% Tween20) for 30 min.
Electron microscopy. MCF-7 cells were prefixed in 2% glutaraldehyde in 0.1 M
phosphate buffer at 4uC. The following experiments were performed by the Hanaichi
Ultra Structure Institute. In brief, the cells were washed overnight in 0.1 M phosphate
buffer at 4uC and were postfixed in 2% osmium tetraoxide for 3 h. The cells were
further dehydrated in a graded ethanol series and embedded in epoxy resin. Ultrathin
sections were stained with 2% uranyl acetate and lead staining solution and observed
with a JEM-1200EX electron microscope. At least 100 mm2 of the cytoplasmic area
was determined to quantify the ratio of the area of autophagic vacuoles to the
cytoplasmic area.
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